Journal of Cell Science & Therapy
Open Access
ISSN: 2157-7013
ISSN: 2157-7013
Jonathan Brenner,Rajen Naidoo
MEDICUS Health & Vitality Clinics,USA
Keynote: J Cell Sci Ther
In 2010 President Barack Obama signed the reversal of the ban on Stem Cell research in the United States and permitted Federal funding of Stem Cell research for 21 Stem Cell lines (Nature 473, 15 (2011)). Since then private funding and industry sponsored clinical studies and clinical use of Stem cells has accelerated and reached the level in which the body of clinical evidence far surpasses the available clinical trials and begs the creation of FDA directed regulation, and granting of Investigational New Drug licenses to further the progress of formal Randomized Prospective Clinical Trials (FDA Clinical Trials.gov). The guidance of the FDA commissioner, Scott Gothlieb, MD in his paper with Peter Marks, MD, PhD ( NEJM 378;10 – 3/8/18) has provided a pathway to the future of stem cell clinical investigation and use once the three year moratorium on regulatory enforcement has expired. This author presents a ten year clinical experience with clinical stem cell administration and discusses the results with treatment of various clinical indications as well as formal clinical studies currently being conducted in the US and other countries.
Dr. Jonathan Brenner, PhD has been selfemployed since he went to college and successfully ran several businesses in the U.S and abroad. Jonathan managed for 10 years the investment banking side of a Broker-Dealer, financing and guiding mostly medical-and biotech companies, orchestrating spin-offs and taking companies public, as well as negotiating and executing JVs and M&A of those companies with Fortune 100 and Fortune 500 companies. He also was a Consultant under President Bush’s initiated Help America Vote Act as well as under President Bush’s initiated No Child Left Behind Act. Besides being the Owner and Chief Executive Officer of MEDICUS, LLC, a Company dedicated to provide Physicians with homeopathic- and bio-identical prescription medications, and MEDICUS Health & Vitality Clinics, both with Headquarters in Tampa, FL, Jonathan is the co-owner of EPR-Technologies, Inc., a Company that has received approximately $14,000,000.00 in Grants from the U.S. Army and $2,500,000.00 in Grants from the U.S. Navy. EPR is a spinoff from the Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine. EPR has a medical device that has proven to save lives through Rapid Profound Hypothermia, in order “to save brains too good to die”. Dr. Naidoo is a physician scientist with a doctorate in Medicine from Yale University, he also holds biomedical engineering degrees and completed Orthopedic Surgical training at Albert Einstein College of Medicine. After a career teaching orthopedic surgery in NYC at Mt Sinai School of Medicine, Dr. Naidoo relocated to Florida where he established an orthopedic practice in Palm Beach and Broward counties. He joined MEDICUS Health & Vitality Clinics in 2018 and was promoted to Chief Medical Officer of the Regenerative Division beginning March 2019. With attention to detail and a profound understanding of how the body moves and functions over time, Dr. Naidoo is able to help his patients heal from their injuries and return to lifestyles they once enjoyed. Dr. Naidoo is a native of South Africa and in his early years proudly served the revolutionary army of Nelson Mandela in South Africa’s struggle for freedom
E-mail: dr.jon.brenner@medicusllc.com